LEADER 01092nam1M2200385--I450- 001 990000358120203316 005 19870324000000.0 020 $bIT 035 $a0035812 035 $aUSA010035812 035 $a(ALEPH)000035812USA01 035 $a0035812 100 $aJul 28, D19911986||||| ITA@01 BA 101 $aITA 102 $aIT 200 1 $aEsercizi di meccanica razionale$fBruno Finzi, Paolo Udeschini 205 $a3. ed 210 $aBologna$cZanichelli$d1991- 215 $av.$d24 cm 606 $aMeccanica razionale - Esercizi 676 $a531.076 700 $aFINZI,$bBruno$0770 801 0$aIT$bICCU$c19980716 912 $a990000358120203316 951 $a531.076 FIN$bIng.$c531.076 959 $aBK 969 $aTEC 979 $aTAMI$b40$c20010314$lUSA01$h1131 979 $aTAMI$b40$c20010314$lUSA01$h1134 979 $aTAMI$b40$c20010314$lUSA01$h1340 979 $aTAMI$b40$c20010314$lUSA01$h1344 979 $c20020403$lUSA01$h1643 979 $aPATRY$b90$c20040406$lUSA01$h1625 996 $aEsercizi di meccanica razionale$9114518 997 $aUNISA LEADER 01310nam a2200301 i 4500 001 991001898769707536 005 20020507153521.0 008 000522s1997 it ||| | ita 020 $a8808169960 035 $ab11580367-39ule_inst 035 $aLE02727064$9ExL 040 $aDip.to Studi Giuridici$bita 084 $aCM-V/A 100 1 $aRossi Vannini, Alessandra$0247325 245 10$aDisposizioni penali.$pTomo 3. :$bart. 232-241 /$cAlessandra Rossi Vannini, Nicola Mazzacuva 260 $aBologna :$bN. Zanichelli ;$aRoma :$bSoc. ed. del Foro italiano,$c1997 300 $axii, 159 p. ;$c26 cm 490 0 $aCommentario Scialoja-Branca.$pLegge fallimentare ;$vArt. 232-241 650 4$aReati fallimentari 700 1 $aMazzacuva, Nicola$eauthor$4http://id.loc.gov/vocabulary/relators/aut$0231804 730 02$aLegge fallimentare$91451946 907 $a.b11580367$b01-03-17$c02-07-02 912 $a991001898769707536 945 $aLE025 ECO 346 LEG01.01$cArt. 232-241$g1$i2025000126466$lle025$o-$pE27.50$q-$rn$so $t0$u0$v0$w0$x0$y.i14325664$z27-11-06 945 $aLE027 CM-V/A 14$g1$i2027000209118$lle027$o-$pE0.00$q-$rl$s- $t0$u1$v0$w1$x0$y.i11787910$z02-07-02 996 $aLegge fallimentare$91451946 997 $aUNISALENTO 998 $a(2)le025$ale027$b01-01-00$cm$da $e-$fita$git $h0$i3 LEADER 03566nam 2200541 a 450 001 9910781798603321 005 20230725050835.0 010 $a0-309-21107-7 010 $a1-283-21343-5 010 $a9786613213433 010 $a0-309-21105-0 035 $a(CKB)2550000000042938 035 $a(EBL)3378803 035 $a(MiAaPQ)EBC3378803 035 $a(Au-PeEL)EBL3378803 035 $a(CaPaEBR)ebr10488624 035 $a(CaONFJC)MIL321343 035 $a(OCoLC)923283637 035 $a(EXLCZ)992550000000042938 100 $a20110827d2011 uy 0 101 0 $aeng 135 $aurcn||||||||| 200 10$aGenerating evidence for genomic diagnostic test development$b[electronic resource] $eworkshop Summary /$fTheresa Wizemann and Adam C. Berger, rapporteurs ; Roundtable on translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies 210 $aWashington, D.C. $cNational Academies Press$d2011 215 $a1 online resource (100 p.) 300 $aDescription based upon print version of record. 311 $a0-309-21104-2 320 $aIncludes bibliographical references. 327 $a""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Contents""; ""Tables, Figures, and Boxes""; ""Abbreviations and Acronyms""; ""1 Introduction""; ""2 Stakeholder Perspectives on Evidence""; ""3 Approaches to Evidence Generation""; ""4 Overcoming Barriers for Evidence Generation""; ""5 Considerations Moving Forward""; ""6 Final Remarks""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker Biographical Sketches""; ""Appendix C: Registered Attendees"" 330 $a"Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person's response to certain drugs, estimate the risk of developing Alzheimer's disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients' health.The Institute of Medicine (IOM) held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests. Generating Evidence for Genomic Diagnostic Test Development compares the evidence that is required for decisions regarding clearance, use, and reimbursement, to the evidence that is currently generated. The report also addresses innovative and efficient ways to generate high-quality evidence, as well as barriers to generating this evidence. Generating Evidence for Genomic Diagnostic Test Development contains information that will be of great value to regulators and policymakers, payers, health-care providers, researchers, funders, and evidence-based review groups."--Publisher's description. 606 $aGenomics 606 $aDiagnosis 606 $aGene mapping 615 0$aGenomics. 615 0$aDiagnosis. 615 0$aGene mapping. 676 $a616.0420027 701 $aWizemann$b Theresa M$0890630 701 $aBerger$b Adam C$01120088 712 02$aInstitute of Medicine (U.S.).$bRoundtable on Translating Genomic-Based Research for Health. 712 02$aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910781798603321 996 $aGenerating evidence for genomic diagnostic test development$93817256 997 $aUNINA